首頁 > 市場調查報告書 > 醫療設備

醫院 IT

市場調查報告書

商品編碼

1820470

全球癌症登記軟體市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及預測（2025 年至 2033 年）

Global Cancer Registry Software Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年09月01日 | 出版商:

Value Market Research | 英文 143 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計 2025 年至 2033 年間，全球癌症登記軟體市場將以 12.84% 的顯著複合年成長率成長。到 2033 年，市場規模預計將飆升至 2.6856 億美元，較 2024 年的 9,055 萬美元大幅成長。

隨著全球醫療保健系統將數據驅動的腫瘤管理和研究置於優先地位，癌症登記軟體市場有望加速成長。這些軟體解決方案有助於系統地收集、儲存和分析癌症患者資料，從而改善流行病學追蹤、治療計劃和療效評估。雲端運算、巨量資料分析和互通性標準的進步正在增強癌症登記平台的可擴展性、可訪問性和整合能力。這項技術進步支持醫院、研究機構和公共衛生機構之間的即時資料共享，促進癌症控制和個人化醫療的合作。

人工智慧和機器學習演算法擴大嵌入到註冊軟體中，用於識別模式、預測疾病進展和最佳化資源分配。增強資料安全性並遵守 HIPAA 和 GDPR 等醫療保健法規至關重要，可確保患者的隱私和信任。電子健康記錄 (EHR) 和健康資訊交換 (HIE) 的日益普及正在推動無縫資料整合，減少人工輸入錯誤並提高資料準確性。此外，使用者友善的介面和可自訂的報告工具使臨床醫生和研究人員能夠有效率地獲得切實可行的見解。

軟體開發人員、腫瘤學專家和政府機構之間的合作正在加速癌症登記解決方案的創新和標準化。隨著全球癌症發生率的上升和精準腫瘤學的進步，癌症登記軟體對於有效的疾病監測、臨床決策和政策制定而言正變得不可或缺，最終將改善患者治療效果並提高醫療保健系統的效率。

我們的報告經過精心設計，旨在為客戶提供關於各個行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵部分，以確保客戶全面了解市場格局：

市場概況：對市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本部分探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準，將市場細分為不同的細分市場。此分析重點在於突出每個細分市場的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本部分深入分析了領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，對特定時期的市場規模和成長趨勢進行預測。這包括定量分析和圖形表示，以說明未來的市場發展軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前及新興市場趨勢、技術創新和潛在投資領域。本部分提供對未來市場發展和成長前景的洞察。

涵蓋的細分市場列表

癌症登記軟體市場報告的此部分提供了國家和地區層面的細分詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按軟體

獨立
融合的

按部署模型

本地部署
基於雲端

按組件

商業的
民眾

按最終用途

政府與第三方
私人付款人
醫院和醫療機構
製藥生物技術和醫療器材公司
研究機構
報告中介紹的公司列表
Elekta AB、Oracle Corporation、ONCO Inc.、國際商業機器公司 (IBM)、McKesson Corporation、Conduent Incorporated、Ordinate Corporation、Volpara Health Technologies Limited、Health Catalyst Inc.、Rocky Mountain Cancer Data Systems（猶他大學健康中心）

如果您有任何客製化需求，請聯絡我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業趨勢
波特五力分析
市場吸引力分析
- 軟體市場吸引力分析
- 按部署模型進行市場吸引力分析
- 各組成部分的市場吸引力分析
- 按最終用途進行的市場吸引力分析
- 市場吸引力分析：按地區

第4章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料製造商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第5章：全球癌症登記軟體市場分析：按軟體

按軟體概覽
透過軟體進行歷史和預測數據分析
獨立
融合的

第6章：全球癌症登記軟體市場分析：依部署模型

按部署模型概述
按部署模型進行歷史和預測資料分析
本地部署
基於雲端

第7章：全球癌症登記軟體市場分析：按組件

按組件概覽
按組件進行歷史和預測資料分析
商業的
民眾

第 8 章：全球癌症登記軟體市場分析：依最終用途

按最終用途概述
按最終用途進行的歷史和預測數據分析
政府與第三方
私人付款人
醫院和醫療機構
製藥生物技術和醫療器材公司
研究機構

第9章：全球癌症登記軟體市場分析：按地區

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第 10 章：癌症登記軟體公司的競爭格局

癌症登記軟體市場競爭
夥伴關係/合作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Elekta AB

公司概況
公司收入
產品
最新動態

Oracle Corporation

公司概況
公司收入
產品
最新動態

ONCO Inc.

公司概況
公司收入
產品
最新動態

International Business Machines Corporation (IBM)

公司概況
公司收入
產品
最新動態

McKesson Corporation

公司概況
公司收入
產品
最新動態

Conduent Incorporated

公司概況
公司收入
產品
最新動態

Ordinate Corporation

公司概況
公司收入
產品
最新動態

Volpara Health Technologies Limited

公司概況
公司收入
產品
最新動態

Health Catalyst Inc.

公司概況
公司收入
產品
最新動態

Rocky Mountain Cancer Data Systems (University Of Utah Health)

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，或者在私人公司的情況下可能不涵蓋

簡介目錄圖表

Product Code: VMR112117613

The Global Cancer Registry Software market is forecasted to grow at a noteworthy CAGR of 12.84% between 2025 and 2033. By 2033, market size is expected to surge to USD 268.56 Million, a substantial rise from the USD 90.55 Million recorded in 2024.

The cancer registry software market is poised for accelerated growth as healthcare systems worldwide prioritize data-driven oncology management and research. These software solutions facilitate the systematic collection, storage, and analysis of cancer patient data, enabling improved epidemiological tracking, treatment planning, and outcome assessment. Advances in cloud computing, big data analytics, and interoperability standards are enhancing the scalability, accessibility, and integration capabilities of cancer registry platforms. This technological evolution supports real-time data sharing among hospitals, research institutions, and public health agencies, fostering collaborative efforts in cancer control and personalized medicine.

Artificial intelligence and machine learning algorithms are increasingly embedded within registry software to identify patterns, predict disease progression, and optimize resource allocation. Enhanced data security and compliance with healthcare regulations such as HIPAA and GDPR are critical features, ensuring patient confidentiality and trust. The growing adoption of electronic health records (EHR) and health information exchanges (HIE) is driving seamless data integration, reducing manual entry errors and improving data accuracy. Additionally, user-friendly interfaces and customizable reporting tools are empowering clinicians and researchers to derive actionable insights efficiently.

Collaborations between software developers, oncology experts, and government bodies are accelerating innovation and standardization in cancer registry solutions. As cancer incidence rises globally and precision oncology advances, cancer registry software is becoming indispensable for effective disease surveillance, clinical decision-making, and policy formulation, ultimately enhancing patient outcomes and healthcare system efficiency.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Cancer Registry Software market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Software

Standalone
Integrated

By Deployment Model

On-premise
Cloud Based

By Component

Commercial
Public

By End-use

Government & Third Party
Private Payers
Hospital & Medical Practice
Pharma Biotech & Medical Device Companies
Research Institutes
List of Companies Profiled in the report
Elekta AB, Oracle Corporation, ONCO Inc., International Business Machines Corporation (IBM), McKesson Corporation, Conduent Incorporated, Ordinate Corporation, Volpara Health Technologies Limited, Health Catalyst Inc., Rocky Mountain Cancer Data Systems (University of Utah Health)

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CANCER REGISTRY SOFTWARE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Software
- 3.7.2 Market Attractiveness Analysis By Deployment Model
- 3.7.3 Market Attractiveness Analysis By Component
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER REGISTRY SOFTWARE MARKET ANALYSIS BY SOFTWARE

5.1. Overview By Software
5.2. Historical and Forecast Data Analysis By Software
5.3. Standalone Historic and Forecast Sales By Regions
5.4. Integrated Historic and Forecast Sales By Regions

6. GLOBAL CANCER REGISTRY SOFTWARE MARKET ANALYSIS BY DEPLOYMENT MODEL

6.1. Overview By Deployment Model
6.2. Historical and Forecast Data Analysis By Deployment Model
6.3. On-premise Historic and Forecast Sales By Regions
6.4. Cloud Based Historic and Forecast Sales By Regions

7. GLOBAL CANCER REGISTRY SOFTWARE MARKET ANALYSIS BY COMPONENT

7.1. Overview By Component
7.2. Historical and Forecast Data Analysis By Component
7.3. Commercial Historic and Forecast Sales By Regions
7.4. Public Historic and Forecast Sales By Regions

8. GLOBAL CANCER REGISTRY SOFTWARE MARKET ANALYSIS BY END-USE

8.1. Overview By End-use
8.2. Historical and Forecast Data Analysis By End-use
8.3. Government & Third Party Historic and Forecast Sales By Regions
8.4. Private Payers Historic and Forecast Sales By Regions
8.5. Hospital & Medical Practice Historic and Forecast Sales By Regions
8.6. Pharma Biotech & Medical Device Companies Historic and Forecast Sales By Regions
8.7. Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL CANCER REGISTRY SOFTWARE MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CANCER REGISTRY SOFTWARE COMPANIES

10.1. Cancer Registry Software Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF CANCER REGISTRY SOFTWARE INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Elekta AB
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Oracle Corporation
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. ONCO Inc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. International Business Machines Corporation (IBM)
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. McKesson Corporation
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Conduent Incorporated
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Ordinate Corporation
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Volpara Health Technologies Limited
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Health Catalyst Inc.
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Rocky Mountain Cancer Data Systems (University Of Utah Health)
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments